Oxford Immunotec Welcomes Updated CDC Recommendations for Tuberculosis Screening and Testing of Healthcare Personnel
May 17, 2019 09:25 ET
|
Oxford Immunotec Global PLC
OXFORD, United Kingdom and MARLBOROUGH, Mass., May 17, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced...
Oxford Immunotec to Present at the UBS Global Healthcare Conference
May 14, 2019 09:20 ET
|
Oxford Immunotec Global PLC
OXFORD, United Kingdom and MARLBOROUGH, Mass., May 14, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced...
Oxford Immunotec Reports First Quarter 2019 Financial Results
May 09, 2019 07:00 ET
|
Oxford Immunotec Global PLC
First quarter revenue of $14.8 million, an increase of 27% compared to prior year periodGross margins expanded 360bps to 71.4%86% reduction in net loss to $1.5m OXFORD, United Kingdom and...
Oxford Immunotec Schedules First Quarter 2019 Earnings Release and Conference Call for May 9, 2019
April 25, 2019 16:05 ET
|
Oxford Immunotec Global PLC
OXFORD, United Kingdom and MARLBOROUGH, Mass., April 25, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today...
Oxford Immunotec Announces New Initiative to Bring the Benefit of Modern Tuberculosis Testing to the Russian Federation
March 28, 2019 07:45 ET
|
Oxford Immunotec Global PLC
OXFORD, United Kingdom and MARLBOROUGH, Mass., March 28, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today...
Oxford Immunotec Announces Chief Financial Officer Transition
March 21, 2019 16:01 ET
|
Oxford Immunotec Global PLC
OXFORD, United Kingdom and MARLBOROUGH, Mass., March 21, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today...
Oxford Immunotec Reports Fourth Quarter and Full Year 2018 Financial Results
March 11, 2019 16:10 ET
|
Oxford Immunotec Global PLC
OXFORD, United Kingdom and MARLBOROUGH, Mass., March 11, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the "Company"), a global, high-growth diagnostics company, today...
Oxford Immunotec to Participate in Two Upcoming Investor Conferences
March 05, 2019 09:00 ET
|
Oxford Immunotec Global PLC
OXFORD, United Kingdom and MARLBOROUGH, Mass., March 05, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that Dr. Peter...
Oxford Immunotec Schedules Fourth Quarter and Full Year 2018 Earnings Release and Conference Call for March 11, 2019
February 19, 2019 16:45 ET
|
Oxford Immunotec Global PLC
OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced...
Oxford Immunotec Announces Board Approval of $100 Million Share Repurchase Program and Reaffirms Growth Expectations for Fourth Quarter 2018
January 06, 2019 19:00 ET
|
Oxford Immunotec Global PLC
OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan. 06, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced...